Low junctional adhesion molecule-A expression is associated with an epithelial to mesenchymal transition and poorer outcomes in high-grade serous carcinoma of uterine adnexa.

Saved in:
Bibliographic Details
Title: Low junctional adhesion molecule-A expression is associated with an epithelial to mesenchymal transition and poorer outcomes in high-grade serous carcinoma of uterine adnexa.
Authors: Communal L; Institut du Cancer de Montréal, Montreal, QC, H2X 0A9, Canada.; Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Montreal, QC, H2X 0A9, Canada., Medrano M; Princess Margaret Cancer Center, University Health Network, Toronto, ON, M5G 1L7, Canada.; Department of Medical Biophysics, University of Toronto, Toronto, ON, M5G 1L7, Canada., Sircoulomb F; Princess Margaret Cancer Center, University Health Network, Toronto, ON, M5G 1L7, Canada., Paterson J; Princess Margaret Cancer Center, University Health Network, Toronto, ON, M5G 1L7, Canada., Köbel M; Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, AB, Canada., Rahimi K; Institut du Cancer de Montréal, Montreal, QC, H2X 0A9, Canada.; Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Montreal, QC, H2X 0A9, Canada.; Department of Pathology, Centre Hospitalier de l'Université de Montréal (CHUM), Montreal, QC, Canada., Hoskins P; BC Cancer, Vancouver, BC, V5Z 1G1, Canada., Tu D; Canadian Cancer Trials Group, Queen's University, Kingston, ON, K7L 3N6, Canada., Lheureux S; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON, M5G 1L7, Canada., Oza A; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON, M5G 1L7, Canada., Ailles L; Princess Margaret Cancer Center, University Health Network, Toronto, ON, M5G 1L7, Canada.; Department of Medical Biophysics, University of Toronto, Toronto, ON, M5G 1L7, Canada., Provencher D; Institut du Cancer de Montréal, Montreal, QC, H2X 0A9, Canada.; Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Montreal, QC, H2X 0A9, Canada.; Division of Gynecologic Oncology, Université de Montréal, Montreal, QC, H3T 1J4, Canada., Rottapel R; Princess Margaret Cancer Center, University Health Network, Toronto, ON, M5G 1L7, Canada.; Department of Medical Biophysics, University of Toronto, Toronto, ON, M5G 1L7, Canada.; Department of Medicine, University of Toronto, Toronto, ON, M5G 2C4, Canada., Mes-Masson AM; Institut du Cancer de Montréal, Montreal, QC, H2X 0A9, Canada. anne-marie.mes-masson@umontreal.ca.; Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Montreal, QC, H2X 0A9, Canada. anne-marie.mes-masson@umontreal.ca.; Department of Medicine, Université de Montréal, Montreal, QC, H3T 1J4, Canada. anne-marie.mes-masson@umontreal.ca.
Source: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc [Mod Pathol] 2020 Nov; Vol. 33 (11), pp. 2361-2377. Date of Electronic Publication: 2020 Jun 08.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 8806605 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1530-0285 (Electronic) Linking ISSN: 08933952 NLM ISO Abbreviation: Mod Pathol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1530-0285
DOI:10.1038/s41379-020-0586-0